Top Gainers That Are Bullish: $YTEN $RENN $NOVN

The Market Signal was created as a platform to help investors, if you own (NASDAQ:YTEN), (NYSE:RENN) or (NASDAQ:NOVN) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.

https://themarketsignal.com/Free-Report/NOW
(Click link above or copy, paste and hit enter in your browser for your report)

Yield10 Bioscience is bullish on news of positive results from CRISPR genome-edited trait C3007

https://themarketsignal.com/Free-Report/YTEN

(Click link above or copy, paste and hit enter in your browser for your report)

Yield10 Bioscience Inc. (NASDAQ:YTEN) was amongst top gainers in yesterday's trading session gaining 53.79%.

Yield10 Bioscience, Inc has announced has announced receiving positive results from CRISPR genome-edited trait C3007 in canola plant lines developed for increased oil content. The results were released by USDA-APHIS's Biotechnology Regulatory Services (BRS).

The company submitted an "Am I regulated?" letter to the BRS in July 2020 requesting the status of its canola plant lines that contain its novel, CRISPR genome-edited C3007 trait.

Renren is bullish and among the top gainers

https://themarketsignal.com/Free-Report/RENN

(Click link above or copy, paste and hit enter in your browser for your report)

Renren Inc. (NYSE:RENN) was amongst top gainers in yesterday's trading session gaining 40.00%.

Renren Inc has announced that its subsidiary in China, Kaixin Auto Holdings has filed a lawsuit against non-controlling shareholders of three of its dealerships due to a dispute on operation matters. The three dealerships accounted for the largest percentage of Kaixin's revenues in 2019. The COVID-19 pandemic has also had adverse effect on Kaixin's which has led to significant loss of revenue.

The company is re-examining its business model in order to sustain its business in the wake of the pandemic. The company has stopped dealership for used cars.

Novan is trending following initiation of B-SIMPLE4 pivotal Phase 3 clinical study of SB206

https://themarketsignal.com/Free-Report/NOVN

(Click link above or copy, paste and hit enter in your browser for your report)

Novan Inc. (NASDAQ:NOVN) was amongst top gainers in yesterday's trading session gaining 27.23%.

Novan, Inc has initiated the B-SIMPLE4 pivotal Phase 3 clinical study of SB206. The product is a tropical antiviral gel used to treat molluscum contagiosum ("molluscum"). According to Novan, Molluscum contagiosum is a contagious skin disease caused by molluscipoxvirus,

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

comtex tracking

COMTEX_371123136/2705/2020-09-11T07:10:03

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.